r.mensah
TL2 Moderator · Aarhus
Contributes reviews on supplier material. Based in Aarhus.
Joined 6 February 2025 · last posted 12h · groups: newcomer-guides
96 posts, newest first. Showing up to 150.
-
Why the cheapest option is often not the cheapest Replied, post #24 · Access › Pricing · 27 Jul 2026 · 29 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
Seven-day rolling means and why weekly readings mislead Replied, post #102 · Outcomes › Progress reports · 24 Jul 2026 · 9 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
What a certificate commits its issuer to Replied, post #76 · Analytics › COA interpretation · 21 Jul 2026 · 0 likes Worth separating two things that post #72 runs together. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #86 · Start Here › Welcome · 3 Jul 2026 · 21 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #110 · Sourcing › Logistics · 22 Jun 2026 · 1 like On post #106 — agreed on the reasoning, with one qualification. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns…
-
Forced degradation studies: designing one that is informative Replied, post #81 · Analytics › Method validation · 21 Jun 2026 · 3 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Revisiting: What pooling buys you and what it destroys Replied, post #62 · Evidence › Meta-analyses · 21 Jun 2026 · 1 like Worth separating two things that post #58 runs together. Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is…
-
Batch numbers that do not match the vial label Replied, post #28 · Sourcing › Red flags · 12 Jun 2026 · 27 likes post #27 answers the question as asked. The question underneath it is different. Safety documentation absent: a supplier that cannot provide information about sterility…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #87 · Evidence › Journal club · 10 Jun 2026 · 21 likes On post #83 — agreed on the reasoning, with one qualification. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #64 · Practice › Storage & stability · 6 Jun 2026 · 7 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #58 · Practice › Interactions · 5 Jun 2026 · 28 likes I read post #56 twice before replying, because I had assumed the opposite. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…
-
Second pass at: Programming during a large energy deficit Replied, post #13 · Nutrition & Training › Resistance training · 4 Jun 2026 · 14 likes On post #9 — agreed on the reasoning, with one qualification. Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #5 · Evidence › Meta-analyses · 14 May 2026 · 29 likes Picking up post #2: that is the part I would want checked first. Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #68 · Data & Tools › Calculators · 1 May 2026 · 11 likes Coming back to post #66, because the follow-up matters more than the original answer. Titration planning: a calculator that shows you the escalation schedule for…
-
Adolescents: a distinct evidence base Started this topic · Clinical › Special populations · 28 Apr 2026 · 23 likes Adolescents: a distinct evidence base Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a…
-
Spreadsheets: an appreciation — what changed since Replied, post #23 · Lounge › Off topic · 20 Apr 2026 · 0 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #39 · Sourcing › Vendor reports · 22 Mar 2026 · 10 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Preprint servers and what screening they do — the long version Replied, post #5 · Evidence › Preprints · 11 Mar 2026 · 0 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #48 · Analytics › Impurities & related substances · 7 Mar 2026 · 1 like Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
The lowest dose that does anything: is that a real question? Replied, post #60 · Practice › Dosing & titration · 5 Mar 2026 · 13 likes post #59 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #5 · Sourcing › Logistics · 23 Feb 2026 · 9 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #24 · Clinical › Bloodwork · 22 Feb 2026 · 0 likes Picking up post #21: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Follow-up: How to disagree with an answer you were given, well Started this topic · Start Here › How to Ask · 17 Feb 2026 · 1 like How to disagree with an answer you were given, well I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title.…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #23 · Compounds › Other compounds · 13 Feb 2026 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Realistic expectations for strength while losing weight quickly Replied, post #59 · Nutrition & Training › Resistance training · 3 Feb 2026 · 1 like Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #12 · Regional › UK & Ireland · 16 Jan 2026 · 9 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
-
A partial dose because the pen emptied mid-injection Replied, post #64 · Practice › Administration · 9 Jan 2026 · 2 likes Picking up post #61: that is the part I would want checked first. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #50 · Regional › UK & Ireland · 9 Jan 2026 · 0 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #49 · Practice › Side effects · 7 Jan 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #37 · Devices › Pens & autoinjectors · 1 Jan 2026 · 0 likes On post #33 — agreed on the reasoning, with one qualification. Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track…
-
Journal club: LEADER as the historical anchor Replied, post #17 · Evidence › Journal club · 29 Dec 2025 · 16 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Second pass at: What pooling buys you and what it destroys Replied, post #4 · Evidence › Meta-analyses · 23 Dec 2025 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Appeal templates and why they are deliberately unemotional Replied, post #27 · Access › Insurance & coverage · 17 Dec 2025 · 15 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Persistent vomiting and the threshold for seeking help Replied, post #83 · Safety › Adverse events · 6 Dec 2025 · 12 likes post #82 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #23 · Compounds › Tirzepatide · 6 Dec 2025 · 0 likes Picking up post #20: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #3 · Practice › Storage & stability · 29 Nov 2025 · 1 like On the opening post — agreed on the reasoning, with one qualification. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #27 · Practice › Reconstitution · 23 Nov 2025 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #16 · Evidence › Trials · 19 Nov 2025 · 1 like The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Lurking for two months before posting: was that the right call? Replied, post #17 · Start Here › Welcome · 17 Nov 2025 · 11 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #14 · Practice › Dosing & titration · 13 Nov 2025 · 3 likes Worth separating two things that post #10 runs together. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #2 · Compounds › Tirzepatide · 12 Nov 2025 · 13 likes I read the opening post twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #97 · Practice › Reconstitution · 12 Nov 2025 · 3 likes Coming back to post #95, because the follow-up matters more than the original answer. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) =…
-
Sleep tracking data and its considerable limitations Replied, post #88 · Wellbeing › Sleep · 25 Oct 2025 · 27 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #45 · Start Here › Welcome · 16 Oct 2025 · 0 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Tracking that stops updating and then resumes — the long version Replied, post #26 · Sourcing › Logistics · 15 Oct 2025 · 29 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Reading an interaction checker output critically Replied, post #22 · Practice › Interactions · 14 Oct 2025 · 16 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Compounds this community declines to help with, and why Replied, post #13 · Compounds › Other compounds · 25 Sep 2025 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #3 · Compounds › Retatrutide · 15 Sep 2025 · 18 likes post #2 is right about the mechanism and I think understates the practical bit. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #5 · Analytics › Impurities & related substances · 3 Sep 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #42 · Analytics › HPLC & UHPLC · 3 Sep 2025 · 8 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #31 · Sourcing › Regulatory · 27 Aug 2025 · 0 likes Worth separating two things that post #27 runs together. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
Are there stupid questions here? A staff answer, at length Replied, post #96 · Start Here › Welcome · 21 Aug 2025 · 21 likes Worth separating two things that post #92 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #48 · Evidence › Journal club · 16 Aug 2025 · 31 likes Coming back to post #46, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #81 · Access › Insurance & coverage · 15 Aug 2025 · 28 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Coming back to: When "no data" is the complete and final answer Replied, post #70 · Compounds › Other compounds · 3 Aug 2025 · 20 likes post #69 is right about the mechanism and I think understates the practical bit. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #62 · Access › Insurance & coverage · 30 Jul 2025 · 1 like Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Antibiotics and a course of something with delayed emptying Replied, post #90 · Practice › Interactions · 14 Jul 2025 · 0 likes post #89 answers the question as asked. The question underneath it is different. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
How to read a forest plot, properly, from scratch Replied, post #4 · Evidence › Trials · 9 Jul 2025 · 3 likes post #2 is right about the mechanism and I think understates the practical bit. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Checking someone else's arithmetic: a worked example thread Replied, post #65 · Practice › Reconstitution · 8 Jul 2025 · 1 like The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
A report I filed that turned out to be wrong, and the correction Replied, post #113 · Sourcing › Vendor reports · 20 Jun 2025 · 14 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Storing a pen in use versus a pen unopened Replied, post #19 · Devices › Pens & autoinjectors · 9 Jun 2025 · 0 likes post #18 answers the question as asked. The question underneath it is different. Off-label dosing with a pen: if you want to deliver a dose different from the pen's…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #57 · Wellbeing › Mental health · 25 May 2025 · 0 likes I read post #55 twice before replying, because I had assumed the opposite. Substance use: if someone has a history of substance use, appetite suppression and weight…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #58 · Practice › Reconstitution · 25 May 2025 · 28 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Travel coolers and how long they really hold — the long version Replied, post #14 · Devices › Cold chain · 21 May 2025 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #45 · Compounds › Repair & healing peptides · 14 May 2025 · 13 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #18 · Compounds › Retatrutide · 9 Apr 2025 · 2 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Adjudicated events and why the definition matters — the long version Replied, post #63 · Evidence › Trials · 24 Mar 2025 · 9 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 23 Mar 2025 · 2 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #77 · Analytics › Mass spectrometry · 22 Mar 2025 · 4 likes Coming back to post #75, because the follow-up matters more than the original answer. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #129 · Sourcing › Vendor reports · 18 Mar 2025 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #89 · Pharmacology › Receptor biology · 13 Mar 2025 · 18 likes post #88 answers the question as asked. The question underneath it is different. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and…
-
Retatrutide dose escalation in the published trials Replied, post #4 · Compounds › Retatrutide · 10 Mar 2025 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Charge states for a 4 kDa peptide, worked through Replied, post #8 · marked as the solution · Analytics › Mass spectrometry · 2 Mar 2025 · 27 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #93 · Compounds › Other compounds · 18 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
When "no data" is the complete and final answer Replied, post #79 · Compounds › Other compounds · 30 Jan 2025 · 32 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Transit times by route, from a logged dataset — the long version Replied, post #52 · Sourcing › Logistics · 23 Jan 2025 · 12 likes Picking up post #49: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Second pass at: Regression to the mean in progress reports Replied, post #23 · Research Methods › Statistics · 13 Jan 2025 · 31 likes I read post #21 twice before replying, because I had assumed the opposite. Relative risk and odds ratios: both compare the rate in one group to the rate in another.…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #43 · Safety › Adverse events · 23 Dec 2024 · 0 likes Worth separating two things that post #39 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Asking about a compound your prescriber has not heard of — one year on Replied, post #15 · Clinical › Prescriber conversations · 11 Dec 2024 · 1 like On post #11 — agreed on the reasoning, with one qualification. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #63 · Practice › Side effects · 11 Dec 2024 · 1 like I read post #61 twice before replying, because I had assumed the opposite. Nausea: the most common side effect and the most dose- and titration-dependent one. It is…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #20 · Nutrition & Training › Protein & intake · 24 Nov 2024 · 19 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Transporting a vial for a weekend away Replied, post #40 · Practice › Storage & stability · 8 Nov 2024 · 1 like Picking up post #37: that is the part I would want checked first. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration.…
-
A page that has drifted out of date and needs a maintainer Replied, post #25 · Documentation › Wiki requests · 4 Nov 2024 · 13 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
People with a low starting BMI: where the evidence stops Replied, post #11 · Clinical › Special populations · 29 Oct 2024 · 0 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #74 · Access › Shortages · 11 Oct 2024 · 4 likes Worth separating two things that post #70 runs together. Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers.…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #64 · Practice › Dosing & titration · 15 Sep 2024 · 0 likes Picking up post #61: that is the part I would want checked first. How the published trials escalated: they used specific step sizes and intervals. The STEP programme…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #52 · Analytics › COA interpretation · 12 Sep 2024 · 1 like Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #11 · Compounds › Tirzepatide · 6 Sep 2024 · 0 likes Picking up post #8: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #30 · Devices › Syringes & needles · 4 Sep 2024 · 11 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
When to suspect the method rather than the sample Replied, post #4 · Analytics › Method validation · 19 Aug 2024 · 12 likes Coming back to post #3, because the follow-up matters more than the original answer. Transfer between laboratories: a method can be transferred from one lab to another,…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #10 · Compounds › Oral incretins · 9 Aug 2024 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #4 · Compounds › Secretagogues & GH axis · 7 Aug 2024 · 22 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #110 · Practice › Dosing & titration · 10 Jul 2024 · 8 likes post #109 answers the question as asked. The question underneath it is different. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
How this community labels and discusses unrefereed work Replied, post #36 · Evidence › Preprints · 23 Jun 2024 · 1 like post #35 answers the question as asked. The question underneath it is different. Always label it as a preprint in any discussion. A preprint is not a published trial…
-
Assessing a warm arrival: the decision process — one year on Replied, post #37 · Sourcing › Logistics · 29 May 2024 · 4 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…